-
New amide and diterpene alkaloids with anticholinesterase activity from Delphinium cyphoplectrum roots DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2024-03-18 Arash Salehi, Behzad Zolfaghari, Mahmoud Aghaei, Hajar Sirous, Morteza Sadeghi, Mohammad Reza Gholami, Parham Reisi, Mustafa Ghanadian
-
Educational interventions in pharmacovigilance to improve the knowledge, attitude and the report of adverse drug reactions in healthcare professionals: Systematic Review and Meta-analysis DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2024-03-01 Mónica J. Cervantes-Arellano, Osvaldo D. Castelán-Martínez, Yolanda Marín-Campos, Juan L. Chávez-Pacheco, Olga Morales-Ríos, Laura M. Ubaldo-Reyes
-
Freeze-drying of bupivacaine lipospheres: preparation, characterization, and evaluation of anti-microbial properties DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2024-02-29
Abstract Purpose To prepare freeze-dried bupivacaine lipospheres intended for topical application in burn injuries. The aim was improving the storage stability and developing a prolonged release pattern to tackle the adverse reactions resulting from the frequent administration of bupivacaine. Methods The lipospheres were prepared by hot-melt dispersion method employing bupivacaine base at 1.5 and 3%w/w
-
Dexmedetomidine alleviates Hypoxia/reoxygenation-induced mitochondrial dysfunction in cardiomyocytes via activation of Sirt3/Prdx3 pathway DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2024-02-26
Abstract Background Myocardial ischemia/reperfusion injury (MIRI) seriously threatens the health of people. The mitochondrial dysfunction in cardiomyocytes can promote the progression of MIRI. Dexmedetomidine (Dex) could alleviate the myocardial injury, which was known to reverse mitochondrial dysfunction in lung injury. However, the function of Dex in mitochondrial dysfunction during MIRI remains
-
Activity of zinc oxide and zinc borate nanoparticles against resistant bacteria in an experimental lung cancer model DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2024-02-17 Demet Celebi, Ozgur Celebi, Ali Taghizadehghalehjoughi, Sumeyye Baser, Elif Aydın, Daniela Calina, Ekaterina Charvalos, Anca Oana Docea, Aristidis Tsatsakis, Yaroslav Mezhuev, Serkan Yildirim
-
Antimicrobial activity and mechanism of anti-MRSA of phloroglucinol derivatives DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2024-01-22 Xianjing Yang, Xinjiao Gao, Jiayi Ou, Gong Chen, Lianbao Ye
-
Oral regimen for high dose methotrexate urine alkalinization: a systematic review and meta-analysis DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2024-01-17 Romina Kaveh-Ahangaran, Mohammad Abdollahi, Mohammad Vaezi, Amir Kasaeian, Zhalleh Bahlouli, Ghasem Janbabaei, Amirmahdi Mojtahedzadeh, Mojtaba Mojtahedzadeh, Shirin Djalalinia, Bita Shahrami
-
A critical overview of challenging roles of medicinal plants in improvement of wound healing technology DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2024-01-15 Deepika Pathak, Avijit Mazumder
-
Co-delivery of artemisinin and metformin via PEGylated niosomal nanoparticles: potential anti-cancer effect in treatment of lung cancer cells DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2024-01-03 Salah Jaafar Abdulkareem, Davoud Jafari-Gharabaghlou, Mahdi Farhoudi-Sefidan-Jadid, Elnaz Salmani-Javan, Fatemeh Toroghi, Nosratollah Zarghami
-
Development of brimonidine niosomes laden contact lenses for extended release and promising delivery system in glaucoma treatment DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2023-12-29 Shresthi Tripathi, Khushwant S. Yadav
-
Imiquimod as a new treatment in refractory idiopathic granulomatous mastitis: report of two cases DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2023-12-28
Abstract Introduction Idiopathic granulomatous mastitis (IGM) is a rare chronic inflammatory lesion of the breast that mimics breast cancer or infection. Immunological pathogenesis is strongly suggested for the disease. Reason for the report The treatment remains controversial, comprising a spectrum from observation or NSAIDs to immunosuppressive agents and surgery. Intractable cases are not uncommon
-
The association between anti-diabetic agents and osteoporosis, sarcopenia, and osteosarcopenia among Iranian older adults; Bushehr Elderly Health (BEH) program DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2023-12-22 Yasmin Heydarzadeh Sohi, Ali Golestani, Ghodratollah Panahi, Ozra Tabatabaei-Malazy, Kazem Khalagi, Noushin Fahimfar, Afshin Ostovar, Mahnaz Sanjari, Bagher Larijani, Iraj Nabipour
-
Artificial viruses: A nanotechnology based approach DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2023-12-18
Abstract Objectives The main objective of this work was to review and summarise the detailed literature available on viral nanoparticle and the strategies utilised for their manufacture along with their applications as therapeutic agents. Data acquisition The reported literature related to development and application of virus nanoparticles have been collected from electronic data bases like ScienceDirect
-
Polymeric nanoparticles delivery circumvents bacterial resistance to ciprofloxacin DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2023-12-15 Abdullah A. Ghawanmeh
-
Multi-functionalization of reduced graphene oxide nanosheets for tumor theragnosis: Synthesis, characterization, enzyme assay, in-silico study, radiolabeling and in vivo targeting evaluation DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2023-12-11 Tamer M. Sakr, Mohammed F. Elsabagh, Hend Fayez, Mona O. Sarhan, Yasmin M. Syam, Manal M. Anwar, Mohammed A. Motaleb, Wafaa A. Zaghary
-
Effectiveness of epigallocatechin gallate nanoparticles on the in-vivo treatment of Alzheimer’s disease in a rat/mouse model: a systematic review DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2023-12-11 Maha K. A. Khalifa, Somaia A. Abdel-Sattar, Omnya M. Amin, Neveen A. Kohaf, Heba S. Zaky, Marwa A. Abd El‑Fattah, Kamilia H. A. Mohammed, Noha M. Badawi, Ihab Mansoor, Heba A. Eassa
-
Fruit vinegar as a promising source of natural anti-inflammatory agents: an up-to-date review DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2023-12-01 Driss Ousaaid, Meryem Bakour, Hassan Laaroussi, Asmae El Ghouizi, Badiaa Lyoussi, Ilham El Arabi
-
Ropivacaine suppresses the progression of renal cell carcinoma through regulating the lncRNA RMRP/EZH2/CCDC65 axis DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2023-11-27 Yingfen Xiong, Xiaolan Zheng, Huangying Deng
-
Electrochemical evaluation of nivolumab used in cancer treatment with differential pulse voltammetry: A novel approach with single-use pencil graphite electrode DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2023-11-22 Mehmet Aslan, Fırat Aydın, Abdulkadir Levent
-
Atypical extrapyramidal manifestation of a typical antipsychotic with serotonergic antidepressant DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2023-11-14 Rohit Singh, Sankha Shubhra Chakrabarti, Upinder Kaur
-
Adrenergic receptors blockade alleviates dexamethasone-induced neurotoxicity in adult male Wistar rats: Distinct effects on β-arrestin2 expression and molecular markers of neural injury DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2023-11-15 Rasha M. S. M. Mohamed, Enssaf Ahmad Ahmad, Dalia M. Amin, Samar Ahmed Abdo, Islam A. A. E.-H. Ibrahim, Mona F. Mahmoud, Shimaa Abdelaal
-
Chidamide inhibits cell glycolysis in acute myeloid leukemia by decreasing N6-methyladenosine-related GNAS-AS1 DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2023-11-06 Changmei Hu, Xiao Fu, Shujun Li, Cong Chen, Xielan Zhao, Jie Peng
-
Towards greater impact in health technology assessment: System dynamic approach for new and emerging technologies in Iran DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2023-11-02 Zahra Goudarzi, Milad Ahmadi Marzaleh, Shekoufeh Nikfar, Abbas Kebriaeezadeh, Reza Yousefi Zenouz, Akbar Abdollahiasl, Mojtaba Nouhi
-
Immediate hypersensitivity reaction to levetiracetam: a case report study DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2023-11-02 Mahnaz Sadat Hosseini, Soha Namazi
-
Computational Screening Using a Combination of Ligand-Based Machine Learning and Molecular Docking Methods for the Repurposing of Antivirals Targeting the SARS-CoV-2 Main Protease DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2023-10-31 Gusti Putu Wahyunanda Crista Yuda, Naufa Hanif, Adam Hermawan
-
Impact of concerning excipients on animal safety: insights for veterinary pharmacotherapy and regulatory considerations DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2023-10-31 Vanessa Cola Thomazini, Gabriel Mendes da Cunha, Nayhara Madeira Guimarães, Soraya Dias Saleme, Rita Cristina Gonçalves de Melo, Geanne Aparecida de Paula, Suzana Gonçalves Carvalho, Marlus Chorilli, Cristiane dos Santos Giuberti, Janaina Cecília Oliveira Villanova
-
Cost minimization analysis of subcutaneous trastuzumab versus intravenous biosimilar trastuzumab: policy recommendations for breast cancer treatment in Malaysia DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2023-10-31 Jin Ee Heng, Sivaraj Raman, Zhi Yen Wong, Valerine Jen Nin Beh
-
Utilization patterns of cardiovascular medications in patients with diabetes mellitus; a retrospective cross-sectional study, 2013-17 DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2023-10-17 Negin Hatami, Mohammad-Reza Malekpour, Farshad Farzadfar, Meysam Seyedifar, Fatemeh Soleymani
-
Prophylactic norepinephrine combined with 6% hydroxyethyl starch (130/0.4) co-load infusion for preventing postspinal anesthesia hypotension during cesarean section: a randomized, controlled, dose-finding trial DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2023-10-09 Lei Guo, Xiangsheng Xiong, Rui Qin, Zhenzhou Li, Yongqiang Shi, Wei Xue, Ling He, Shuqin Ma, Yi Chen
-
Identifying natural products for gastric cancer treatment through pharmacophore creation, 3D QSAR, virtual screening, and molecular dynamics studies DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2023-09-21 Zeinab Jalali, Samad Nejad Ebrahimi, Hassan Rezadoost
-
Vactosertib potently improves anti-tumor properties of 5-FU for colon cancer DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2023-09-23 Maryam Moradi Binabaj, Fereshteh Asgharzadeh, Farzad Rahmani, Abdulridha Mohammed Al-Asady, Milad Hashemzehi, Atena Soleimani, Amir Avan, Saeedeh Mehraban, Elnaz Ghorbani, Mikhail Ryzhikov, Majid Khazaei, Seyed Mahdi Hassanian
-
Comparison of different transient gene expression systems for the production of a new humanized anti-HER2 monoclonal antibody (Hersintuzumab) DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2023-09-11 Ali Roshani, Mehdi Mohammadi, Tannaz Bahadori, Hengameh Ahmadi Zare, Mohammad Ali Judaki, Maryam Mobini, Forough Golsaz-Shirazi, Mahmood Jeddi-Tehrani, Mohammad Mehdi Amiri, Fazel Shokri
-
Firstly electrochemical investigetions and determination of anticoagulant drug edoxaban at single-use pencil graphite electrode: an eco-friendly and cost effective voltammetric method DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2023-09-11 Abdulkadir Kiliç , Mehmet Aslan, Günay Önal, Abdulkadir Levent
-
Designing and psychometric evaluation of pharmacists' attitude toward ethical challenges questionnaire in pharmacy practice: A mixed‑method study DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2023-09-01 Rasool Esmalipour, Pooneh Salari, Abbas Ebadi, Neda Mehrdad, Bagher Larijani
-
Clove volatile oil-loaded nanoemulsion reduces the anxious-like behavior in adult zebrafish DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2023-08-28 Matheus da Silva Campelo, João Francisco Câmara Neto, Álamo Lourenço de Souza, Maria Kueirislene Amâncio Ferreira, Hélcio Silva dos Santos, Nilce Viana Gramosa, Sandra de Aguiar Soares, Nágila Maria Pontes Silva Ricardo, Jane Eire Silva Alencar de Menezes, Maria Elenir Nobre Pinho Ribeiro
-
A self-healable and bioadhesive acacia gum polysaccharide-based injectable hydrogel for wound healing acceleration DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2023-08-23 Zainab Ahmadian, Mahsa Zibanejad Jelodar, Marzieh Rashidipour, Masoumeh Dadkhah, Vahed Adhami, Sajjad Sefareshi, Hossein Ali Ebrahimi, Motaleb Ghasemian, Mohsen Adeli
-
COVID-19: A novel holistic systems biology approach to predict its molecular mechanisms (in vitro) and repurpose drugs DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2023-08-19 Marzieh Sameni, Seyed Amir Mirmotalebisohi, Sadaf Dadashkhan, Sepideh Ghani, Maryam Abbasi, Effat Noori, Hakimeh Zali
-
Tenofovir alafenamide plus dolutegravir as a switch strategy in HIV-infected patients: a pilot randomized controlled trial DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2023-08-04 Golbarg Alavian, Ladan Abbasian, Hossein Khalili, Seyed Ahmad Seyed Alinaghi, Malihe Hasannezhad, Masoumeh Farrokh Ashtiani, Seyed Ali Dehghan Manshadi
-
In silico screening, synthesis, characterization and biological evaluation of novel anticancer agents as potential COX-2 inhibitors DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2023-07-15 Ankita Sahu, Dibyabhaba Pradhan, Babita Veer, Sumit Kumar, Ram Singh, Khalid Raza, Moshahid A. Rizvi, Arun Kumar Jain, Saurabh Verma
-
A neuroprotective dose of trehalose is harmless to metabolic organs: comprehensive histopathological analysis of liver, pancreas, and kidney DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2023-07-01 Diego Armando Morales-Carrizales, Yareth Gopar-Cuevas, Maria de Jesus Loera-Arias, Odila Saucedo-Cardenas, Roberto Montes de Oca-Luna, Aracely Garcia-Garcia, Humberto Rodriguez-Rocha
-
The use of therapeutic drug monitoring to highlight an over-looked drug-drug interaction leading to imatinib treatment failure DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2023-06-15 Sara Gagno, Angela Buonadonna, Chiara Dalle Fratte, Michela Guardascione, Martina Zanchetta, Bianca Posocco, Marco Orleni, Giovanni Canil, Rossana Roncato, Erika Cecchin, Giuseppe Toffoli
-
Network pharmacology: a systems perspective possible underpinning approach for oral cancer treatment DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2023-05-25 Pandiyan Muthuramalingam, Rajakumar Govindasamy, Baskar Venkidasamy, Murugesan Krishnan, Hyunsuk Shin
-
Cardiac safety profile of type II kinase inhibitors: Analysis of post-marketing reports from databases of European Medicine Agency & World Health Organization DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2023-05-23 Atul Khurana, Mandeep Kumar Arora, Harikesh Dubey
-
Simulation of drug-drug interactions between breast cancer chemotherapeutic agents and antiemetic drugs DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2023-05-24 Subrata Deb, Robert Hopefl
-
Fabrication, characterization and evaluation of a new designed botulinum toxin-cell penetrating peptide nanoparticulate complex DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2023-05-20 Nazanin Shabani Ravari, Maryam Ghareh Sheikhlou, Navid Goodarzi, Bahar Kharazian, Mohsen Amini, Fatemeh Atyabi, Saman A. Nasrollahi, Rassoul Dinarvand
-
Flavonoid as possible therapeutic targets against COVID-19: a scoping review of in silico studies DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2023-05-17 Larissa Toigo, Emilly Isabelli dos Santos Teodoro, Ana Carolina Guidi, Naiara Cássia Gancedo, Marcus Vinícius Petruco, Eduardo Borges Melo, Fernanda Stumpf Tonin, Fernando Fernandez-Llimos, Danielly Chierrito, João Carlos Palazzo de Mello, Daniela Cristina de Medeiros Araújo, Andréia Cristina Conegero Sanches
-
Fibroblast growth factor 2 reduces endoplasmic reticulum stress and apoptosis in in-vitro Non-Alcoholic Fatty Liver Disease model DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2023-05-09 Seyedeh Parisa Hosseini, Shirin Farivar, Ramazan Rezaei, Samaneh Tokhanbigli, Behzad Hatami, Mohammad Reza Zali, Kaveh Baghaei
-
Novel therapeutic approach for the treatment of cystic fibrosis based on freeze-dried tridrug microparticles to treat cystic fibrosis DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2023-05-04 Vinayak D. Kabra, Swaroop R. Lahoti
-
Trimethoprim/sulfamethoxazole desensitization in an HIV-positive patient with previous Stevens-Johnson syndrome; a failed study DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2023-03-31 Ramin Ansari, Sara Ghaderkhani , Soha Namazi
-
Resveratrol and Dulaglutide ameliorate adiposity and liver dysfunction in rats with diet-induced metabolic syndrome: Role of SIRT-1 / adipokines / PPARγ and IGF-1 DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2023-03-29 Hanan Abdel Moneam A. Shamardl, Noha A. Ibrahim, Dina H. Merzeban, Azza M. Elamir, Rehab M. Golam, Asmaa M. Elsayed
-
Eradicating the tumor “seeds”: nanomedicines-based therapies against cancer stem cells DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2023-03-27 Lin Li, Rui Ni, Dan Zheng, Lin Chen
-
Lipid nanoparticles for gene therapy in ocular diseases DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2023-02-15 Christian Chapa González, Jessica Victoria Martínez Saráoz, Jorge Alberto Roacho Pérez, Imelda Olivas Armendáriz
-
Availability and affordability of cardiovascular medicines in a major city of Afghanistan in 2020 DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2022-11-17 Fatemeh Kokabisaghi, Amir Hashemi-Meshkini, Asaad Obewal, Vahid Ghavami, Javad Javan-Noughabi, Hamidreza Shabanikiya, Mehdi Varmaghani, Javad Moghri
Purpose Affordable access to quality medicines is a critical target of global efforts to achieve universal health coverage. The aim of this study is to measure the affordability and accessibility of cardiovascular medicines in the city of Herat, Afghanistan. Methods The price, affordability, and availability data for 18 most sold generic (MSG) and lowest priced generic (LPG) products were collected
-
Mesoporous silica coated SPIONs containing curcumin and silymarin intended for breast cancer therapy DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2022-10-05 Soosan Sadegha, Reyhaneh Varshochian, Pegah Dadras, Hosniyeh Hosseinzadeh, Ramin Sakhtianchi, Zahra Hadavand Mirzaie, Akram Shafiee, Fatemeh Atyabi, Rassoul Dinarvand
-
A review on the synthesis of bio-based surfactants using green chemistry principles DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2022-10-03 Shea Stubbs, Sakib Yousaf, Iftikhar Khan
-
Adverse drug reactions of Rituximab in patients suffering from autoimmune neurological diseases DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2022-09-24 Niayesh Mohebbi, Maryam Taghizadeh-Ghehi, Seyed Mehrdad Savar, Siamak Abdi, Romina Kouhsari, Kheirollah Gholami, Shahriar Nafissi
-
Effect of vitamins C and E on cancer survival; a systematic review DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2022-09-22 Shahrzad Mohseni, Ozra Tabatabaei-Malazy, Hanieh-Sadat Ejtahed, Mostafa Qorbani, Leila Azadbakht, Patricia Khashayar, Bagher Larijani
-
Dapsone improves the vincristine-induced neuropathic nociception by modulating neuroinflammation and oxidative stress DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2022-09-15 Sevda Shayesteh, Mina Khalilzadeh, Nasrin Takzaree, Ahmad Reza Dehpour
-
Novel biodegradable molecularly imprinted polymer nanoparticles for drug delivery of methotrexate anti-cancer; synthesis, characterization and cellular studies DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2022-09-10 Sepideh Yoosefi, Mehdi Esfandyari-Manesh, Fatemeh Ghorbani-Bidkorpeh, Mahnaz Ahmadi, Fatemeh Moraffah, Rassoul Dinarvand
-
Pharmacokinetic study of high-dose oral rifampicin in critically Ill patients with multidrug-resistant Acinetobacter baumannii infection DARU J. Pharm. Sci. (IF 4.088) Pub Date : 2022-09-07 Hossein Karballaei-Mirzahosseini, Romina Kaveh-Ahangaran, Bita Shahrami, Mohammad Reza Rouini, Atabak Najafi, Arezoo Ahmadi, Sima Sadrai, Amirmahdi Mojtahedzadeh, Farhad Najmeddin, Mojtaba Mojtahedzadeh